Insights On Pharmaceutical Packaging
-
Quick View Of Asymchem's New OEB5 Facility
3/12/2026
Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.
-
Asymchem's State-Of-The-Art HTE Platform
3/12/2026
Steve Fussell, Senior Manager – High-Throughput Experimentation (HTE) at Asymchem, introduces our state-of-the-art HTE laboratory, where automation, robotics, and data-driven insights transform process R&D.
-
ATLAS Label Translation Solution
3/4/2026
By simplifying label requests, integrating expert translation and regulatory support, and enabling a fully paperless approval workflow, organizations can reduce turnaround times while maintaining high-quality label content.
-
Advancing Health Through Decades Of Packaging Innovation
2/27/2026
A legacy of packaging expertise evolved into a mission centered on helping life‑changing medicines reach people. See how purpose, curiosity, and partnership drive continued growth.
-
What To Look For In A Pharma Contract Packaging Partner
2/27/2026
Teams face rising pressure around compliance, complexity, and speed. These five essential qualities help identify packaging partners who can support production, reduce risk, and align with your needs.
-
Choosing The Right Pharma CMO: The 3 Cs That Matter Most
2/27/2026
Choosing a CMO is a strategic decision that shapes long‑term quality and scalability. Discover how a focused framework helps teams identify partners that can adapt and support growing portfolios.
-
Robotics And AI In Pharma: Driving The Next Wave Of Innovation
2/23/2026
Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.
-
The Critical Role Of Clinical Trial Packaging Services In Trial Success
1/26/2026
Compliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.
-
Precision and Compliance in Pharmaceutical Packaging
1/26/2026
Reliable, compliant packaging preserves product integrity, supports regulatory readiness, and lowers risk. Careful components and controlled processes keep complex therapies protected.
-
5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market
1/22/2026
To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.